Becton, Dickinson and Company logo

Becton, Dickinson and Company (BDX)

Market Closed
5 Sep, 20:00
NYSE NYSE
$
192. 39
+1.13
+0.59%
$
55.31B Market Cap
- P/E Ratio
3.8% Div Yield
1,244,193 Volume
- Eps
$ 191.26
Previous Close
Day Range
190.83 192.97
Year Range
163.33 251.99
Want to track BDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 60 days
Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson

Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson

Shares of Edwards Lifesciences Corp. EW, -1.14% rallied 3% in premarket trading Monday, after the company announced an agreement to sell its critical care product group to Becton Dickinson & Co. BDX, +2.29% in a cash deal valued at $4.2 billion. Edwards said it plans to use the proceeds from the sale to fund investments for growth, such as in technologies for technologies for aortic, mitral, tricuspid and pulmonic patients, and in therapeutic areas for interventional heart failure.

Marketwatch | 1 year ago
Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement

Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement

NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

Accesswire | 1 year ago
My Best Dividend Aristocrats For June 2024

My Best Dividend Aristocrats For June 2024

The ProShares S&P 500 Dividend Aristocrats ETF hits its first speed bump in April, dropping by 4.69%. Some of this loss has been recovered in May. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 34 months of tracking these strategies, one strategy is outperforming NOBL, while 2 remain relatively close.

Seekingalpha | 1 year ago
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access

BD's (BDX) FDA-Approved Test to Offer Wider Testing Access

BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.

Zacks | 1 year ago
Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement

Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action Settlement

NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX). The settlement provides for a fund of $85,000,000 to benefit class members.

Accesswire | 1 year ago